Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD)
08 oct. 2024 04h00 HE
|
Somagenetix AG
ZURICH, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Somagenetix AG, a pioneering biotech company dedicated to revolutionizing gene therapy for phagocyte disorders, announced today the initial closing of its...
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
30 juil. 2024 10h00 HE
|
KabaFusion
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited...
Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels
13 mai 2024 09h00 HE
|
Baylor Genetics
Baylor Genetics today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS).
Global HIV Treatment Market Report 2023: Enhanced Diagnostic Capabilities Fuels Growth
31 mai 2023 07h28 HE
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030" report has been added to ...
Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants
21 sept. 2022 12h54 HE
|
Lactiga, Inc
NORTH BRUNSWICK, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary...
Lactiga Continues to Build a Substantial Global Biologics Patent Portfolio
20 juil. 2021 09h00 HE
|
Lactiga, Inc
PRINCETON, N.J., July 20, 2021 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), a biotherapeutics company advancing anti-infective biologics to prevent mucosal infections in immunodeficient patients,...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
02 nov. 2020 10h00 HE
|
Checkmate Capital
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing anti-infective biologics, is pleased to announce the completion of...
Nufactor® Selected by Grifols to be Included in the Limited Network of Specialty Pharmacies for XEMBIFY®
12 déc. 2019 17h23 HE
|
FFF Enterprises.com
TEMECULA, Calif., Dec. 12, 2019 (GLOBE NEWSWIRE) -- TEMECULA, Calif. — Nufactor, Inc., a specialty infusion company and subsidiary of FFF Enterprises, Inc. (FFF) has been selected by Grifols to be...
Preventing Anaphylaxis
01 août 2019 14h06 HE
|
The Jackson Laboratory
Farmington, Connecticut, Aug. 01, 2019 (GLOBE NEWSWIRE) -- An antibody, known as IgE, is the culprit in allergic reactions to everything from peanuts to tree pollen. A kind of super-antibody, known...
Global Markets for Blood Plasma Products to Reach $23B by 2021
09 août 2017 05h00 HE
|
BCC Research
WELLESLEY, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Rising demand for immunoglobulins is the main driver of the global market for blood plasma products, which has the potential to reach $23...